BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20435660)

  • 21. Prognostic value of visceral pleural invasion in resected non-small cell lung cancer diagnosed by using a jet stream of saline solution.
    Maruyama R; Shoji F; Okamoto T; Miyamoto T; Miyake T; Nakamura T; Ikeda J; Asoh H; Yamaguchi M; Yoshino I; Ichinose Y
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1587-92. PubMed ID: 15173711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphatic invasion is a more significant prognostic factor than visceral pleural invasion in non-small cell lung cancer with tumours of 3 cm or less.
    Moon Y; Park JK; Lee KY; Sung SW
    Respirology; 2017 Aug; 22(6):1179-1184. PubMed ID: 28382791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Impact of visceral pleural invasion on the prognosis of stage Ib non-small cell lung cancer].
    Su XD; Long H; Wang X; Fu JH; He JH; Lin P; Zhang LJ; Ma GW
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):368-71. PubMed ID: 18953838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcome and late recurrence in patients with completely resected stage IA non-small cell lung cancer.
    Maeda R; Yoshida J; Ishii G; Aokage K; Hishida T; Nishimura M; Nishiwaki Y; Nagai K
    J Thorac Oncol; 2010 Aug; 5(8):1246-50. PubMed ID: 20559152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer.
    Kim IH; Lee IH; Lee JE; Hong SH; Kim TJ; Lee KY; Kim YK; Kim SJ; Sung SW; Park JK; Yoo IR; Kim YS; Kim JO; Kang JH
    Clin Lung Cancer; 2016 Sep; 17(5):e31-e43. PubMed ID: 26992846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of histologic differentiation, carcinoembryonic antigen value, and lymphovascular invasion in stage I non-small cell lung cancer.
    Kuo SW; Chen JS; Huang PM; Hsu HH; Lai HS; Lee JM
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1200-1207.e3. PubMed ID: 24993621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Impact of Margins on Outcomes After Wedge Resection for Stage I Non-Small Cell Lung Cancer.
    Wolf AS; Swanson SJ; Yip R; Liu B; Tarras ES; Yankelevitz DF; Henschke CI; Taioli E; Flores RM;
    Ann Thorac Surg; 2017 Oct; 104(4):1171-1178. PubMed ID: 28669499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of vascular and lymphovascular invasion in early lung cancer.
    Al-Alao BS; Gately K; Nicholson S; McGovern E; Young VK; O'Byrne KJ
    Asian Cardiovasc Thorac Ann; 2014 Jan; 22(1):55-64. PubMed ID: 24585645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late recurrence of non-small cell lung cancer more than 5 years after complete resection: incidence and clinical implications in patient follow-up.
    Maeda R; Yoshida J; Hishida T; Aokage K; Nishimura M; Nishiwaki Y; Nagai K
    Chest; 2010 Jul; 138(1):145-50. PubMed ID: 20382716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphovascular space invasion and tumor differentiation are predictors for postoperative recurrence in patients with pathological stage I nonsmall cell lung cancer.
    Chen YY; Huang TW; Tsai WC; Lin LF; Cheng JB; Lee SC; Chang H
    J Chin Med Assoc; 2014 Aug; 77(8):416-21. PubMed ID: 25028298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mortality in early-stage, surgically resected non-small cell lung cancer less than 3 cm of size: Competing risk analysis].
    Jordá Aragón C; Peñalver Cuesta JC; Mancheño Franch N; de Aguiar Quevedo K; Vera Sempere F; Padilla Alarcón J
    Med Clin (Barc); 2015 Sep; 145(5):185-91. PubMed ID: 25433784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer.
    Brown LM; Louie BE; Jackson N; Farivar AS; Aye RW; Vallières E
    Ann Thorac Surg; 2016 Oct; 102(4):1110-8. PubMed ID: 27350237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer.
    Shoji F; Morodomi Y; Akamine T; Takamori S; Katsura M; Takada K; Suzuki Y; Fujishita T; Okamoto T; Maehara Y
    Lung Cancer; 2016 Aug; 98():15-21. PubMed ID: 27393501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
    Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The prognostic impact of preoperative PET-CT on postoperative recurrence for completely resected stage I non-small cell lung cancer].
    Qiang G; Xu R; Liu J; Yan J; Xu Y; Di J; Da J; Liang C; Shi B; Guo Y; Liu D
    Zhonghua Wai Ke Za Zhi; 2015 Jul; 53(7):502-7. PubMed ID: 26359072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visceral pleural invasion impacts the prognosis of non-small cell lung cancer: A meta-analysis.
    Liu QX; Deng XF; Zhou D; Li JM; Min JX; Dai JG
    Eur J Surg Oncol; 2016 Nov; 42(11):1707-1713. PubMed ID: 27178776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.
    Miyoshi K; Moriyama S; Kunitomo T; Nawa S
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):429-34. PubMed ID: 19185165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor recurrence after complete resection for non-small cell lung cancer.
    Taylor MD; Nagji AS; Bhamidipati CM; Theodosakis N; Kozower BD; Lau CL; Jones DR
    Ann Thorac Surg; 2012 Jun; 93(6):1813-20; discussion 1820-1. PubMed ID: 22542070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of pleural recurrence after percutaneous transthoracic needle biopsy in stage I non-small-cell lung cancer.
    Ahn SY; Yoon SH; Yang BR; Kim YT; Park CM; Goo JM
    Eur Radiol; 2019 Jan; 29(1):270-278. PubMed ID: 29948086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.